Document is current
Any future updates will be listed below
-
Authors
Angi, Eleonora
Ferrarini, Federica
Lanubile, Alessia
Montenegro, Francesca
Albano, Melina
Mazzucato, Silvia
Reggiani, Francesco
Amaro, Adriana A.
Indraccolo, Stefano
Minuzzo, Sonia
-
Funding
Funding for this research was provided by:
Italian Ministry of Health (Fondo Ricerca Corrente 2024)
- License Information
-
More Information
Article History
Received: 5 August 2025
Accepted: 21 November 2025
First Online: 3 January 2026
Declarations
:
: Procedures involving animals conformed to current laws and policies (EEC Council Directive 2010/63/EU, OJ L 276, 20.10.2010) were authorized by the Italian Ministry of Health (189/2022-PR).
: Not applicable.
: S. Indraccolo is a co-inventor of the patent “Histone deacetylase 6 inhibitors for the treatment of acute lymphoblastic leukaemia with T cells (T-ALL) and other neoplasms with high expression of Notch3” (Italian patent No. 102017000086293, granted on 29 November 2019; international patent application No. PCT/IB2018/05560, filed on 26 July 2018 and granted as US Patent No. 11,478,475 B2 on 25 October 2022). Other authors declare that they have no competing interests.
